Castleman Disease Latest Advances
Find the Latest Research About Castleman Disease
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4115 publications
The Kaposi's sarcoma-associated herpesvirus viral genome packaging accessory factor ORF68 forms cytoplasmic puncta dependent on the viral tyrosine kinase.
Journal: bioRxiv : the preprint server for biology
Published: April 09, 2026
The 516th case: hyperinflammatory state, acute renal dysfunction, hepatosplenomegaly with lymphadenopathy, and recurrent cerebral infarctions
Journal: Zhonghua nei ke za zhi
Published: April 06, 2026
Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease.
Journal: Drug discoveries & therapeutics
Published: April 01, 2026
CRE26-069: Human Herpesvirus-8 Associated Multicentric Castleman Disease Presenting as Secondary Hemophagocytic Lymphohistiocytosis in Human Immunodeficiency Virus Infection.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Recovery trajectories of TAFRO syndrome: a single-center case series highlighting prolonged thrombocytopenia and anasarca.
Journal: Immunological medicine
Published: March 23, 2026
Angiomatous Subtype of Penile Kaposi Sarcoma With Concurrent HIV-Negative Multicentric Castleman Disease: A Case Report.
Journal: International journal of surgical pathology
Published: March 23, 2026
Retraction of: Multicentric Castleman disease presenting with frequent urination.
Journal: Rheumatology (Oxford, England)
Published: March 17, 2026
Breast-implant associated unicentric castleman disease: a case report.
Journal: Current problems in cancer. Case reports
Published: March 16, 2026
Interfollicular Plasmacytosis and Hyperplastic Germinal Centers in Idiopathic Multicentric Castleman Disease, Idiopathic Plasmacytic Lymphadenopathy Subtype.
Journal: American journal of hematology
Published: March 04, 2026
Mesenteric unicentric Castleman's disease misdiagnosed as gastrointestinal neuroendocrine tumour.
Journal: BMJ case reports
Published: February 19, 2026
Systemic bone destruction as a presentation of idiopathic multicentric Castleman disease.
Journal: British journal of haematology
Published: February 16, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.
Journal: Frontiers in oncology
Published: February 16, 2026
Last Updated: 04/28/2026